Dr. Charu Ramchandani, MD

Dr. Ramchandani practices at Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System.

Dr. Ramchandani's NPI, 1831487321, was assigned on July 18, 2011. Dr. Ramchandani holds New York license 275378.

Dr. Ramchandani's primary practice is Greenwich Hospital, at 5 Perryridge Rd, Greenwich, CT 06830 in Fairfield County. The practice phone is (203) 863-3000.

Dr. Ramchandani's primary practice is Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System. Dr. Ramchandani is also affiliated with Montefiore St. Luke's Cornwall. The medical group on file is Northeast Medical Group. Dmand AI also links Dr. Ramchandani to 5 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramchandani practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Ramchandani's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Ramchandani's licenses on file in 2 states: New York and Connecticut.

CMS data shows 80 Medicare services from Dr. Ramchandani across 4 procedure codes in 2024, for 59 Medicare patients. Medicare paid $8,194 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 59 Medicare patients who saw Dr. Ramchandani in 2024. The largest group is 85 and over, with 21 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramchandani's median patient age at 73, with 52% women.

In 2024, Dr. Ramchandani wrote 63 Medicare Part D claims for 21 patients. 83% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $6,118 in total drug cost. In 2018, CMS named 160 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ramchandani for performance year 2024, reported through an alternative payment model (APM). Dr. Ramchandani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Ramchandani from 4 drug and device companies from 2019 to 2021. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $125.